18-day 16-board Shuangcheng Pharmaceutical (002693.SZ): There is uncertainty about whether the restructuring matters can finally be successfully implemented

Zhitong Finance App News, Shuangcheng Pharmaceutical (002693.SZ) issued an announcement. The cumulative deviation value of the company's stock trading price increase was more than 20% for two consecutive trading days on October 14, 2024 and October 15, 2024. According to the relevant regulations of the Shenzhen Stock Exchange, this is a situation where stock trading fluctuates abnormally.

The company is planning major asset restructuring matters. The company plans to purchase 100% of its shares from 25 counterparties, including Ola Investment and Win Aiming, by issuing shares and paying cash, and plans to raise supporting capital by issuing shares to no more than 35 specific investors. As of the disclosure date of this announcement, the audit and evaluation of this transaction has not been completed, and the specific transaction price of this transaction has not yet been determined. The restructuring has yet to go through the necessary internal decision-making procedures and must be approved by the competent supervisory authority before it can be formally implemented. There is uncertainty about whether it will eventually be successfully implemented.

Other than the above matters, the company, controlling shareholders, and actual controllers have no important matters relating to the company that should have been disclosed but not disclosed.